Hyperlipoproteinemia Type IIa, Elevated LDL Medications
Drugs (by generic name) associated with Hyperlipoproteinemia Type IIa, Elevated LDL
The following drugs and medications are in some way related to, or used in the treatment of Hyperlipoproteinemia Type IIa, Elevated LDL. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Hyperlipoproteinemia Type IIa, Elevated LDL Medications in the Pipeline
- June 20, 2008 - Merck Provides Update on U.S. Regulatory Status of MK-0524A (ER niacin/laropiprant) and MK-0524B (ER niacin/laropiprant/simvastatin)
- April 29, 2008 - Merck Receives Not Approvable Letter from FDA for MK-0524A (ER niacin/laropiprant)
- August 29, 2007 - Merck Announces FDA Acceptance of NDA for Cordaptive (ER niacin/laropiprant), Formerly Known as MK-0524A, an Investigational Lipid-Modifier
Latest Hyperlipoproteinemia Type IIa, Elevated LDL Blog Post
New Study Demonstrates Improvements in LDL-Cholesterol on Top of Statin Therapy with HEP-40, a Novel Natural Product
NEW YORK--(BUSINESS WIRE)--Apr 3, 2009 - Diversified Natural Products, Inc. reported results of a new study presented this week at the 58th annual Scientific Sessions of the American College of Cardiology, demonstrating that the addition of HEP-40 (enzymatically...
View all Hyperlipoproteinemia Type IIa, Elevated LDL blog posts.
Hyperlipoproteinemia Type IIa, Elevated LDL Support Group Questions
Go to the Hyperlipoproteinemia Type IIa, Elevated LDL support group or view all Hyperlipoproteinemia Type IIa, Elevated LDL questions.
